CROI 2017 Program and Information

Program and Agenda

Poster P-U4 PREP PERSISTENCE, ADHERENCE, AND OUTCOMES Poster Hall - 4 EF 972 IMPACT OF INSURANCE COVERAGE ON PREEXPOSURE PROPHYLAXIS FOR HIV PREVENTION Rupa R. Patel 1 , Leandro Mena 2 , Amy Nunn 3 , Timothy McBride 1 , Laura C. Harrison 1 , Catherine E. Oldenburg 4 , Jingxia Liu 1 , Kenneth H. Mayer 5 , Philip A. Chan 6 1 Washington Univ in St. Louis, St. Louis, MO, USA, 2 Univ of Mississippi, Jackson, MS, USA, 3 Brown Univ, Providence, RI, USA, 4 Univ of California San Francisco, San Francisco, USA, 5 Fenway Hlth, Boston, USA, 6 The Miriam Hosp, Providence, RI, USA 973 CONCORDANT POPULATION-LEVEL INCREASES IN PREP FOUND WITHNOVEL PUBLIC HEALTHMETHODS Susan Buskin 1 , Julia Hood 1 , Sara N. Glick 2 , Warren Dinges 3 , Matthew R. Golden 2 1 Pub Hlth–Seattle & King County, Seattle, WA, USA, 2 Univ of Washington, Seattle, WA, USA, 3 Seattle Infectious Disease Clinic, Seattle, WA, USA 974 RACIAL/ETHNIC DISPARITIES IN PERSISTENCE AMONG PREP USERS IN SAN FRANCISCO Hyman Scott 1 , Miranda Nordell 1 , Anne Hirozawa 1 , Monica Gandhi 2 , Catherine James 1 , Hali Hammer 1 , Susan Buchbinder 1 , Susan Scheer 1 1 San Francisco Dept of Pub Hlth, San Francisco, CA, USA, 2 Univ of California San Francisco, San Francisco, CA, USA 975 URINE TENOFOVIR TESTING TOMEASURE PREP ADHERENCE AMONG YOUTH IN A REALWORLD SETTING Linden Lalley-Chareczko 1 , Devon Clark 1 , Ganesh S. Moorthy 2 , Athena Zuppa 3 , Caitlin Conyngham 1 , KaramMounzer 1 , Pablo Tebas 2 , Helen C. Koenig 2 1 Philadelphia FIGHT, Philadephia, PA, USA, 2 Univ of Pennsylvania, Philadephia, PA, USA, 3 Children’s Hosp of Philadelphia, Philadephia, PA, USA 976 COMBININGMEASURES OF ADHERENCE CAN ASSESS PATTERNS OF PREP DRUG-TAKING AndrewM. Abaasa 1 , Craig Hendrix 2 , Monica Gandhi 3 , Peter Anderson 4 , Anatoli Kamali 5 , Eduard Sanders 6 , Gaudensia Mutua 7 , Frances Priddy 5 , Haberer Jessica 8 1 MRC/UVRI Uganda Rsr Unit on AIDS, Entebbe, Uganda, 2 The Johns Hopkins Univ, Baltimore, MD, USA, 3 Univ of California San Francisco, San Francisco, CA, USA, 4 Univ of Colorado, Aurora, CO, USA, 5 Intl AIDS Vaccine Initiative, New York, NY, USA, 6 Kenya Med Rsr Inst, Kilifi, Kenya, 7 Univ of Nairobi, Nairobi, Kenya, 8 Cntr for Global Hlth, Massachusetts General Hosp, Boston, MA, USA 977 SUBSTANCE-USINGMSMONHIV PREEXPOSURE PROPHYLAXIS HAVE BETTER ADHERENCE Martin Hoenigl 1 , Sonia Jain 2 , David J Moore 1 , Deborah Collins 3 , Xiaoying Sun 2 , Peter L. Anderson 4 , Katya Calvo 5 , Michael Dube 6 , Sheldon Morris 1 , for the California Collaborative Treatment Group (CCTG) 595 Team 1 Univ of California San Diego, San Diego, CA, USA, 2 Univ of California San Diego, La Jolla, CA, USA, 3 Long Beach HHS, Long Beach, CA, USA, 4 Univ of Colorado Denver, Aurora, CO, USA, 5 Los Angeles Biomed Rsr Inst at Harbor– UCLA Med Cntr, Torrance, CA, USA, 6 Univ of Southern California, Los Angeles, CA, USA 2:30 PM - 4:00 PM

Poster Sessions • Wednesday

CROI 2017 161